Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M17.0Revenue $M46.9Net Margin (%)0Z-Score5.1
Enterprise Value $M-0.2EPS $-1.0Operating Margin %0F-Score3
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)0Higher ROA y-yY
Price/Book1.010-y EBITDA Growth Rate %-49.8Quick Ratio20.8Cash flow > EarningsY
Price/Sales05-y EBITDA Growth Rate %-44.9Current Ratio20.8Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-51.4Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-54.5Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M21.0ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with ABIO

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ABIOJean-Marie Eveillard 2010-03-31 Sold Out -0.01%$2.64 - $8.22
($3.15)
$ 0.81-74%Sold Out0
ABIOJean-Marie Eveillard 2009-12-31 Reduce$2.25 - $4.32
($3.01)
$ 0.81-73%Reduce -27.96%412,321
ABIOJean-Marie Eveillard 2009-09-30 Add0.01%$2.28 - $4.4
($3.48)
$ 0.81-77%Add 62.38%572,321
ABIOJean-Marie Eveillard 2009-06-30 Sold Out -0.02%$2.58 - $13.45
($6.95)
$ 0.81-88%Sold Out0
ABIOJean-Marie Eveillard 2009-03-31 Buy 0.02%$3.99 - $6.4
($5.2)
$ 0.81-84%New holding, 283453 sh.283,453
ABIOJean-Marie Eveillard 2008-12-31 Sold Out -0.02%$5.4 - $7.4
($6.1)
$ 0.81-87%Sold Out0
ABIOJean-Marie Eveillard 2008-09-30 Add0.01%$8.4 - $13
($10)
$ 0.81-92%Add 109.51%3,698,447
ABIOJean-Marie Eveillard 2008-03-31 Buy $13 - $36
($28)
$ 0.81-97%New holding, 1800000 sh.1,800,000
ABIOGeorge Soros 2006-12-31 Sold Out $78.8 - $393.8
($310)
$ 0.81-100%Sold Out0
ABIOGeorge Soros 2006-06-30 Buy 0.04%$298 - $347.8
($324)
$ 0.81-100%New holding, 20000 sh.20,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ABIO is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


ABIO: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Wheeler Patrick MCFO 2014-09-18Sell8,246$1.31-38.17 view
BRISTOW MICHAEL RPresident and CEO 2014-09-18Sell13,853$1.3-37.69 view
mccormack riley10% Owner 2014-02-04Buy1,000,000$1.7-52.35 view
mccormack riley10% Owner 2013-09-27Sell0$0-52.35 view
Atlas Venture Fund VII L P10% Owner 2012-10-25Sell0$0-52.35 view
Grais Linda SDirector 2010-03-29Sell210,809$7.38-89.02 view
Wheeler Patrick MActing CFO 2009-12-07Sell0$0-89.02 view
Lowe David GeorgeDirector 2009-07-21Sell205,800$4.22-80.81 view
FALBERG KATHRYN ECFO and COO 2009-06-16Sell21,000$3.61-77.56 view
Skyline Venture Partners QualiFormer 10% owner 2009-06-15Sell50,600$3.86-79.02 view

Press Releases about ABIO :

    Quarterly/Annual Reports about ABIO:

    News about ABIO:

    Articles On GuruFocus.com
    comment on ABIO Mar 15 2013 
    ARCA BIOPHARMA, INC. Reports Operating Results (10-Q) Nov 15 2010 
    ARCA BIOPHARMA, INC. Reports Operating Results (10-Q) Aug 10 2010 
    ARCA BIOPHARMA, INC. Reports Operating Results (10-Q) May 10 2010 
    ARCA BIOPHARMA, INC. Reports Operating Results (10-Q) Nov 16 2009 
    ARCA BIOPHARMA, INC. Reports Operating Results (10-Q) Aug 10 2009 
    ARCA biopharma Inc. Reports Operating Results (10-Q) May 15 2009 
    ARCA biopharma Inc. Reports Operating Results (10-Q) Feb 07 2009 

    More From Other Websites
    ARCA BIOPHARMA, INC. Financials Nov 21 2014
    10-Q for ARCA biopharma, Inc. Nov 14 2014
    ARCA BIOPHARMA, INC. Files SEC form 10-Q, Quarterly Report Nov 12 2014
    LabCorp/ARCA biopharma GENETIC-AF Poster Presented at the 18th Annual Scientific Meeting of the... Sep 16 2014
    LabCorp/ARCA biopharma GENETIC-AF Poster Selected for Presentation at the 18th Annual Scientific... Sep 08 2014
    ARCA BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Aug 18 2014
    ARCA biopharma Announces Health Canada Acceptance of Genetic-AF Clinical Trial Application Aug 18 2014
    ARCA BIOPHARMA, INC. Files SEC form 10-Q, Quarterly Report Aug 13 2014
    ARCA Biopharma: An Undervalued Biotech With A Bright Future Jul 03 2014
    ARCA BIOPHARMA, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Other... Jun 09 2014
    Robert E. Conway Elected Chairman of ARCA biopharma Board of Directors Jun 09 2014
    5 Stocks Under $10 Set to Soar May 29 2014
    ARCA BIOPHARMA, INC. Files SEC form 10-Q, Quarterly Report May 13 2014
    ARCA biopharma to Present at the Growth Capital Expo 2014 Apr 22 2014
    ARCA biopharma Announces Screening of First Patient in Phase 2B/3 Clinical Trial Evaluating Gencaro... Apr 17 2014
    ARCA biopharma Files Shelf Registration Statement Apr 04 2014
    Checking In On ARCA Biopharma Mar 25 2014
    ARCA BIOPHARMA, INC. Files SEC form 10-K, Annual Report Mar 20 2014
    ARCA biopharma CEO Michael R. Bristow to Be Interviewed Live Today on Clear Channel Business Talk... Mar 19 2014
    Small-Cap Biotech on the Verge of a Breakout: ABIO Mar 12 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK